Nienke Golüke

Dr. Nienke Golüke

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2022 in Bone Reports
Verified
Journal Article
Open access
NGNienke Golüke
Nienke Golüke
MSMarit A. Schoffelmeer
Marit A. Schoffelmeer
AJAnnemarieke De Jonghe
Annemarieke De Jonghe
MEMariëlle H. Emmelot-Vonk
Mariëlle H. Emmelot-Vonk
PJPim A. De Jong
Pim A. De Jong
HKHuiberdina L. Koek
Huiberdina L. Koek
To clarify the role of mediators of ectopic mineralization as biomarkers for arterial calcifications. MEDLINE and Embase were searched for relevant literature, until January 4th 2022. The investigated biomarkers were: calcium, phosphate, parathyroid hormone, vitamin D, pyrophosphate, osteoprotegerin, receptor activator of nuclear factor-kappa B ligand (RANKL), fibroblast growth factor-23 (FGF-23), Klotho, osteopontin, osteocalcin, Matrix Gla protein (MGP) and its inactive forms and vitamin K. Studies solely performed in patients with kidney insufficiency or diabetes mellitus were excluded. After screening of 8985 articles, a total of 129 articles were included in this systematic review. For all biomarkers included in this review, the results were variable and more than half of the studies for each specific biomarker had a non-significant result. Also, the overall quality of the included studies was low, partly as a result of the mostly cross-sectional study designs. The largest body of evidence is available for phosphate, osteopontin and FGF-23, as a little over half of the studies showed a significant, positive association. Firm statements for these biomarkers cannot be drawn, as the number of studies was limited and hampered by residual confounding or had non-significant results. The associations of the other mediators of ectopic mineralization with arterial calcifications were not clear. Associations between biomarkers of ectopic mineralization and arterial calcification are variable in the published literature. Future longitudinal studies differentiating medial and intimal calcification could add to the knowledge of biomarkers and mechanisms of arterial calcifications.

1 November 2019 in Maturitas
Verified
Journal Article
Closed access
NGNienke Golüke
Nienke Golüke
IVIrene E. van de Vorst
Irene E. van de Vorst
IVIlonca H. Vaartjes
Ilonca H. Vaartjes
MGMirjam I. Geerlings
Mirjam I. Geerlings
AJAnnemarieke de Jonghe
Annemarieke de Jonghe
HKHuiberdina L. Koek
Huiberdina L. Koek

7 March 2020 in Age and Ageing
Verified
Journal Article
Open access
PDF file
IVIrene E. Van De Vorst
Irene E. Van De Vorst
NGNienke Golüke
Nienke Golüke
IVIlonca Vaartjes
Ilonca Vaartjes
MBMichiel L Bots
Michiel L Bots
Huiberdina Lena KoekHuiberdina Lena Koek
Huiberdina Lena Koek
Objective: to develop a model to predict one- and three-year mortality in patients with dementia attending a hospital, through hospital admission or day/memory clinic. Design: we constructed a cohort of dementia patients through data linkage of three Dutch national registers: the hospital discharge register (HDR), the population register and the national cause of death register. Subjects: patients with dementia in the HDR aged between 60 and 100 years registered between 1 January 2000 and 31 December 2010. Methods: logistic regression analysis techniques were used to predict one- and three-year mortality after a first hospitalisation with dementia. The performance was assessed using the c-statistic and the Hosmer–Lemeshow test. Internal validation was performed using bootstrap resampling. Results: 50,993 patients were included in the cohort. Two models were constructed, which included age, sex, setting of care (hospitalised versus day clinic) and the presence of comorbidity using the Charlson comorbidity index. One model predicted one-year mortality and the other three-year mortality. Model discrimination according to the c-statistic for the models was 0.71 (95% CI 0.71–0.72) and 0.72 (95% CI 0.72–0.73), respectively. Conclusion: both models display acceptable ability to predict mortality. An important advantage is that they are easy to apply in daily practise and thus are helpful for individual decision-making regarding diagnostic/therapeutic interventions and advance care planning.

10 November 2019 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Open access
PDF file
NGNienke Golüke
Nienke Golüke
MGMirjam I. Geerlings
Mirjam I. Geerlings
IVIrene E. Van De Vorst
Irene E. Van De Vorst
IVIlonca H. Vaartjes
Ilonca H. Vaartjes
AJAnnemarieke de Jonghe
Annemarieke de Jonghe
HKHuiberdina L. Koek
Huiberdina L. Koek
Objective: To examine the mortality risk, and its risk factors, of older patients with dementia in psychiatric care.Methods: We constructed a cohort of dementia patients through data linkage of four Dutch registers: the Psychiatric Case Register Middle Netherlands (PCR‐MN), the hospital discharge register, the population register, and the national cause of death register. All dementia patients in PCR‐MN aged between 60 and 100 years between 1 January 2000 and 31 December 2010 were included. Risk factors of mortality were investigated using Cox proportional hazard regression models with adjustment for age, sex, setting of care, nationality, marital status, dementia type, and psychiatric and somatic comorbidities.Results: In total, 4297 patients were included with a median age of 80 years. The 1‐year, 3‐year, and 5‐year mortality were 16.4%, 44.4%, and 63.5%, respectively. Determinants that increased the 1‐year mortality were: male sex (adjusted hazard ratio [HR]: 1.49; 95% confidence interval [95% CI], 1.26‐1.76), higher age (HR 1.08; 95% CI, 1.07‐1.09), inpatient psychiatric care (HR 1.52; 95% CI, 1.19‐1.93), more somatic comorbidities (HR 1.67; 95% CI, 1.49‐1.87), and cardiovascular disease separately (HR 1.54; 95% CI, 1.30‐1.82). Results for 3‐year and 5‐year mortality were comparable. Living together/married increased the 3‐ and 5‐year mortality, and Dutch nationality increased the 5‐year mortality. There were no differences in mortality with different types of psychiatric comorbidity.Conclusion: Mortality of dementia patients in psychiatric care was high, much higher than mortality in the general older population. The results of this study should raise awareness about their unfavourable prognosis, particularly older patients, men, inpatients, and patients with more somatic comorbidity.

31 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GMGini Mathijssen
Gini Mathijssen
EVEvelien van Valen
Evelien van Valen
Pim de JongPim de Jong
Pim de Jong
NGNienke Golüke
Nienke Golüke
EMEmiel A. van Maren
Emiel A. van Maren
Huiberdina Lena KoekHuiberdina Lena Koek
Huiberdina Lena Koek
(1) Background: Primary Familial Brain Calcification (PFBC) is a neurodegenerative disease characterized by bilateral calcifications of the basal ganglia and other intracranial areas. Many patients experience symptoms of motor dysfunction and cognitive disorders. The aim of this study was to investigate the association between the amount and location of intracranial calcifications with these symptoms. (2) Methods: Patients with suspected PFBC referred to our outpatient clinic underwent a clinical work-up. Intracranial calcifications were visualized on Computed Tomography (CT), and a Total Calcification Score (TCS) was constructed. Logistic and linear regression models were performed. (3) Results: Fifty patients with PFBC were included in this study (median age 64.0 years, 50% women). Of the forty-one symptomatic patients (82.0%), 78.8% showed motor dysfunction, and 70.7% showed cognitive disorders. In multivariate analysis, the TCS was associated with bradykinesia/hypokinesia (OR 1.07, 95%-CI 1.02–1.12, p < 0.01), gait ataxia (OR 1.06, 95%-CI 1.00–1.12, p = 0.04), increased fall risk (OR 1.04, 95%-CI 1.00–1.08, p = 0.03), and attention/processing speed disorders (OR 1.06, 95%-CI 1.01–1.12, p = 0.02). Calcifications of the lentiform nucleus and subcortical white matter were associated with motor and cognitive disorders. (4) Conclusions: cognitive and motor symptoms are common among patients with PFBC, and there is an association between intracranial calcifications and these symptoms.

1 August 2023 in Neurology Clinical Practice
Verified
Journal Article
Open access
PDF file
NGNienke Golüke
Nienke Golüke
EMEnrico Meijer
Enrico Meijer
EMEmiel A. van Maren
Emiel A. van Maren
AJAnnemarieke de Jonghe
Annemarieke de Jonghe
MEMariëlle H. Emmelot-Vonk
Mariëlle H. Emmelot-Vonk
HKHuiberdina L. Koek
Huiberdina L. Koek
Background and Objectives In clinical practice, it can be difficult to differentiate between intracranial calcifications related to primary familial brain calcification (PFBC) or aging. Also, little is known about the consequences of the amount of intracranial calcifications in patients with PFBC. Therefore, we aimed to compare the amount and distribution of intracranial calcifications in persons with PFBC with controls and between asymptomatic and symptomatic PFBC cases. Methods This was a case-control study including patients with PFBC and controls. Controls received a CT of the brain because of a trauma and had at least some basal ganglia calcification. The Nicolas score and volume of calcification were used to quantify intracranial calcifications on the CT scans. Receiver operating characteristic curves were obtained to calculate optimal cutoff points to discriminate between cases and controls. Mann-Whitney U tests and logistic regression, adjusted for age and sex, were used to compare the amount of calcification. Results Twenty-eight cases (median age 65 years, 50.0% male) and 90 controls (median age 74 years, 46.1% male) were included. Calcification scores were higher in cases (median volume: 4.91 cm3 against 0.03 cm3, p < 0.001, median Nicolas score: 26.5 against 2.0, p < 0.001) than controls. Calcifications were also more diffusely distributed in cases. To differentiate between cases and controls, optimal cutoff points were ≥0.2 cm3 for the calcification volume and ≥6.0 for the Nicolas score. Calcification was higher for symptomatic than asymptomatic cases (calcification volume: 13.62 cm3 against 1.61 cm3, p = 0.01, Nicolas score: 39.0 against 15.5, p = 0.02). After adjustment for age and sex, the Nicolas score remained significantly higher in symptomatic patients, and the calcification volume did not. Discussion Patients with PFBC had more severe intracranial calcifications, and these calcifications were more diffusely distributed through the brain compared with controls. Symptomatic patients with PFBC might have more intracranial calcifications than asymptomatic persons.